LIGAND PHARMACEUTICALS INCORPORATED (LGNYZ) Stock buybacks 2016–2025
LIGAND PHARMACEUTICALS INCORPORATED (LGNYZ) annual stock buyback history — cash paid to repurchase common stock, per SEC filings.
$15.0MFY2025 · since FY2016: $3.9M → $15.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $15.0M | — |
| FY2024 | $0 | — |
| FY2023 | $0 | — |
| FY2022 | $0 | — |
| FY2021 | $0 | -100.0% |
| FY2020 | $78.0M | -82.8% |
| FY2019 | $453.0M | +268.7% |
| FY2018 | $122.9M | +6149.6% |
| FY2017 | $2.0M | -49.6% |
| FY2016 | $3.9M | — |
Source: SEC XBRL filings · For reference only · Not investment advice